Compare UTF & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UTF | TMDX |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2004 | 2019 |
| Metric | UTF | TMDX |
|---|---|---|
| Price | $25.80 | $68.99 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $98.73 |
| AVG Volume (30 Days) | 234.1K | ★ 864.1K |
| Earning Date | 01-01-0001 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | N/A | $22.50 |
| Revenue Next Year | N/A | $17.97 |
| P/E Ratio | ★ N/A | $119.27 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $23.42 | $60.11 |
| 52 Week High | $28.11 | $156.00 |
| Indicator | UTF | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 60.45 | 47.66 |
| Support Level | $25.28 | $66.77 |
| Resistance Level | $27.35 | $79.60 |
| Average True Range (ATR) | 0.35 | 3.94 |
| MACD | 0.07 | 0.18 |
| Stochastic Oscillator | 76.06 | 68.31 |
Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. Under normal market conditions, the fund invests the majority of its managed assets in securities issued by infrastructure companies, which consist of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.